All Aseptic compounding units for chemotherapy (both NHS and Commercial) are coming under increased MHRA scrutiny and there is a major focus on the robustness of the Quality Management systems including environmental monitoring and capacity.
A large number of NHS and commercial sites have found themselves with a partial or complete suspension of their licences until the Quality System is beck under control and the capacity figures back in the green.
A recent client of mine was facing these issues, a backlog of overdue quality management actions (Change Controls, Deviations, Risk assessments, and Root Cause Analyses) a large number of these documents were also being raised as the issues which should have been addressed were still open (bringing numerous repeat issues). Capacity was a major issue as there were several posts unfilled and no real investment in QA. Our first task was to reduce the considerable backlog and where possible find root causes and create appropriate measurable CAPA actions.
By clearing the backlog and putting appropriate CAPA in place the occurrence of errors was reduced. By clarifying the deviation process we have seen a reduction in ‘real’ deviations and are able to trend minor errors which help us spot opportunities for improvement.
We have put simple systems in place which:-
- Provide a risk-based approach to Production, Quality Assurance, Quality Control, Environmental Monitoring and Regulatory Compliance
- Create simple, accurate and valuable KPI data which;
- Report in real-time
- Is easy for the trust to follow
- Highlights issues clearly
- Track trends
- Manage the capacity and;
- Show production performance against both predicted and actual workload
- Evaluate capacity prospectively to show where the extra resource should be spent
- Show QA resource requirement against both reactive and proactive tasks
- Have well described and documented actions to be carried out if a real or predicted overcapacity situation occurs.
- Create a simple manageable management structure which is easy to follow and easier to show roles and responsibilities
- Elevate the microbiology staff and the environmental monitoring actions to a smoothly run well-understood machine which easily spots any trend data, can quickly react to any environmental threats and has brought previously devolved activities back in house.
- Have increased the capability and cross-functional effectiveness of all staff
- Create an environment where there is sufficient capacity to support long term projects
- Create a culture of interdependent facilities and a multifunctional workforce
- Drive continuous improvement
This client has now had its licence reinstated.
We now have a system which can be replicated in other trusts and other licenced aseptic units. This blueprint has been inspected by the MHRA and accepted as appropriate to the regulations.
If you want a system which has been audited by the MHRA and passed if you want a system which your regulator has seen before, if you would like us to come in and evaluate your suitability to run with our system or if you want a bespoke system just for you please mail info@29eye.com and we’ll arrange a preliminary meeting to discuss your requirements. We have the experience to make your trip out of IAG back into licenced manufacture simple.